EMvision Medical Devices Ltd. (AU:EMV) has released an update.
EMVision Medical Devices Ltd has successfully commenced its pilot commercial production line and received the last installment of a $1.25 million grant from the Modern Manufacturing Initiative. This development marks a milestone for the Australian medical device company, which is focused on bringing its non-invasive emu™ brain scanner to market, aiming to enhance the diagnosis and treatment of strokes and other emergencies. The new production line is designed to build and test up to three devices per week, signaling a significant step towards commercial availability.
For further insights into AU:EMV stock, check out TipRanks’ Stock Analysis page.
